Pfizer Limited
Pfizer Limited, a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in India and operates extensively across the Asia-Pacific region. Founded in 1849, Pfizer has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines and vaccines that address critical health challenges. The company is renowned for its diverse portfolio, which includes treatments in areas such as oncology, cardiology, immunology, and infectious diseases. Pfizer Limited's commitment to research and development has led to significant breakthroughs, making its products unique in efficacy and safety. With a strong market position, Pfizer Limited has achieved numerous accolades for its contributions to healthcare, including the rapid development of vaccines during public health emergencies. This dedication to improving patient outcomes solidifies its reputation as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Pfizer Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Limited's score of 19 is lower than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer Limited's reported carbon emissions
In 2024, Pfizer Limited reported total carbon emissions of approximately 2,475,000 kg CO2e for Scope 2 and 57,000 kg CO2e for Scope 1 in India. This reflects a commitment to reducing their carbon footprint, with a significant focus on improving operational efficiency. In 2023, the company recorded higher emissions, with Scope 1 at 63,000 kg CO2e and Scope 2 at 3,653,000 kg CO2e, indicating a positive trend in emissions reduction. Pfizer Limited has set ambitious reduction targets, achieving a 26% decrease in carbon emissions per million tablets produced, reducing from 0.98 tonnes to 0.72 tonnes between 2023 and 2024. This reduction applies to both Scope 1 and Scope 2 emissions, showcasing their commitment to sustainability and climate action. The company has not disclosed any Scope 3 emissions data, but their focus on reducing direct and indirect emissions aligns with industry standards for climate responsibility. Pfizer Limited's ongoing initiatives reflect a proactive approach to mitigating climate impact and enhancing environmental performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 149,000 | 00,000 |
| Scope 2 | 3,433,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pfizer Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
